Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Phase I/II trial of non-cytotoxic suramin in combination with weekly paclitaxel in metastatic breast cancer treated with prior taxanes.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Phase I/II trial of non-cytotoxic suramin in combination with weekly paclitaxel in metastatic breast cancer treated with prior taxanes.
Phase I/II trial of non-cytotoxic suramin in combination with weekly paclitaxel in metastatic breast cancer treated with prior taxanes. Cancer Chemother Pharmacol. 2012 Jul; 70(1):49-56.
View in:
PubMed
subject areas
Adult
Adult
Aged
Aged
Antineoplastic Combined Chemotherapy Protocols
Antineoplastic Combined Chemotherapy Protocols
Breast Neoplasms
Breast Neoplasms
Disease-Free Survival
Disease-Free Survival
Dose-Response Relationship, Drug
Dose-Response Relationship, Drug
Drug Administration Schedule
Drug Administration Schedule
Fatigue
Fatigue
Female
Female
Fibroblast Growth Factor 2
Fibroblast Growth Factor 2
Humans
Humans
Leukopenia
Leukopenia
Middle Aged
Middle Aged
Nausea
Nausea
Neoplasm Metastasis
Neoplasm Metastasis
Paclitaxel
Paclitaxel
Suramin
Suramin
Taxoids
Taxoids
Treatment Outcome
Treatment Outcome